16-28 of 28

Pediatric Narcolepsy: Psychological and Social Comorbidities
MinuteCE®Pediatric Narcolepsy: Psychological and Social Comorbidities

Current Pharmacologic Approaches to Managing Pediatric Narcolepsy
MinuteCE®Current Pharmacologic Approaches to Managing Pediatric Narcolepsy

Evolving Therapy for Managing Pediatric Narcolepsy: Once-Nightly Sodium Oxybate
MinuteCE®Evolving Therapy for Managing Pediatric Narcolepsy: Once-Nightly Sodium Oxybate

Evolving Therapy for Managing Pediatric Narcolepsy: Wake-Promoting Pitolisant
MinuteCE®Evolving Therapy for Managing Pediatric Narcolepsy: Wake-Promoting Pitolisant

Can We Talk? Optimizing Patient and Parent/Caregiver Buy-in to the Management of Pediatric Narcolepsy
MinuteCE®Can We Talk? Optimizing Patient and Parent/Caregiver Buy-in to the Management of Pediatric Narcolepsy

Duchenne Muscular Dystrophy: Differentiating Advances in Treatment
CME/CEDuchenne Muscular Dystrophy: Differentiating Advances in Treatment
- advertisement

Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
MinuteCE®Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism

CASR and ADH1: Integrating Biology and Genetic Screening
MinuteCE®CASR and ADH1: Integrating Biology and Genetic Screening

Therapeutic Options for ADH1 and Hypoparathyroidism
MinuteCE®Therapeutic Options for ADH1 and Hypoparathyroidism

Emerging Therapeutics in ADH1: Progress in Precision Medicine
MinuteCE®Emerging Therapeutics in ADH1: Progress in Precision Medicine

Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
CME/CETitrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
- advertisement

Evolving Perspectives in PIK3CA-related Overgrowth Spectrum Diagnosis & Treatment
CME/CEEvolving Perspectives in PIK3CA-related Overgrowth Spectrum Diagnosis & Treatment










































